The Multidisciplinary Treatment of Fibromyalgia.
Launched by INSTITUT INVESTIGACIO SANITARIA PERE VIRGILI · Sep 13, 2018
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
A descriptive analysis of the sociodemographic characteristics of the intervention and control groups was done. Qualitative variables were expressed as percentages, and quantitative variables were summarised as the median and interquartile range.
Shapiro-Wilk tests indicated that the dependent variables were not normally distributed (p \< .05), so non-parametric statistical analyses were subsequently performed. The difference between the medians of the two patient groups was examined with the Mann-Whitney U test. Qualitative variables were compared with the chi-squared or Fisher's exact te...
Gender
ALL
Eligibility criteria
- Eligibility Criteria inclusion intervention group:
- • to be diagnosed with FM
- • to be between 18 and 80 years old
- • be a patient of the unit care of FM
- • the patients have to participate in nine of the treatment sessions
- • the patients have to make the first visit in the unit care of FM during 2016
- Eligibility Criteria inclusion control group:
- • to be diagnosed with FM
- • to be between 18 and 80 years old
- • to be a member of the FM Patient Association of Terres de l'Ebre
- Eligibility Criteria exclusion control intervention and group:
- • not understanding Catalan or Spanish
- • not providing correct contact data
Trial Officials
ANNA LLADSER NAVARRO, NR, MsC
Principal Investigator
Institut Investigacio Sanitaria Pere Virgili
About Institut Investigacio Sanitaria Pere Virgili
Institut d'Investigació Sanitària Pere Virgili (IISPV) is a leading biomedical research institute based in Tarragona, Spain, dedicated to advancing health through innovative research and clinical trials. Affiliated with the University Rovira i Virgili and the Joan XXIII University Hospital, IISPV focuses on translating scientific discoveries into clinical applications to improve patient care. With a multidisciplinary team of researchers and clinicians, the institute emphasizes collaboration and excellence in various fields, including oncology, cardiovascular health, and infectious diseases. IISPV's commitment to fostering research innovation and enhancing healthcare outcomes positions it as a key player in the global scientific community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials